The Dolutegravir Transition in West Africa: Best Practices, Lessons Learned, and Next Steps

Feb 2, 2022

On Tuesday, February 5, 2022, CQUIN in collaboration with the Clinton Health Access Initiative, CHAI, convened a webinar to explore the use of dolutegravir treatment in West Africa.

Case Studies

The DTG transition: Lessons from Côte d’Ivoire
Dr. MathurinKouadjalé, Head of Care and Treatment Services, MOH/PNLS Cote d’Ivoire

The DTG transition: Lessons from Nigeria
Ehimen Etiobhio, Senior Medical Officer, MOH/NASCP Nigeria

Panel Discussion

Dr. Nandita Sugandhi, Senior Program Office, ICAP Columbia
Dr. Patricia Fassinou, Scientific and Programmatic Director, EGPAF Côte d’Ivoire
Dr. Christine Malati, Senior Clinical Pharmacist, USAID
Mr. Valentin Nassara, Secretary-General, Benin Network of Associations of Persons Living with HIV
Dr. Bineta Coulibaly, MOH Senegal

Slide Presentations

English French Portuguese

 

Webinar Recordings

English Portuguese

More News

Countries Make Significant Progress in Improving Differentiated HIV Testing One Year After Introduction of CQUIN HIV Testing Self-Assessment Tool
Countries Make Significant Progress in Improving Differentiated HIV Testing One Year After Introduction of CQUIN HIV Testing Self-Assessment Tool
Liberia’s First DSD Performance Review Indicates Significant Improvements in Scaling Up and Diversifying DSD Programs in the Country’s Capital County
Liberia’s First DSD Performance Review Indicates Significant Improvements in Scaling Up and Diversifying DSD Programs in the Country’s Capital County
ICAP and PATA Receive Funding From Gates Foundation to Support the Elimination of Vertical Transmission in Six African Countries
ICAP and PATA Receive Funding From Gates Foundation to Support the Elimination of Vertical Transmission in Six African Countries
Perspectives From the CQUIN Integration Meeting — What Will it Take for Countries to Scale Up Non-HIV Services Into DSD Programs?
Perspectives From the CQUIN Integration Meeting — What Will it Take for Countries to Scale Up Non-HIV Services Into DSD Programs?